1. Home
  2. RNW vs EVO Comparison

RNW vs EVO Comparison

Compare RNW & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ReNew Energy Global plc

RNW

ReNew Energy Global plc

HOLD

Current Price

$6.24

Market Cap

2.2B

Sector

Utilities

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.02

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNW
EVO
Founded
2011
1993
Country
United Kingdom
Germany
Employees
4336
4553
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RNW
EVO
Price
$6.24
$2.02
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
$7.00
$7.00
AVG Volume (30 Days)
1.4M
39.3K
Earning Date
06-15-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1.37
Revenue Next Year
$11.50
$10.05
P/E Ratio
$14.63
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.39
$2.10
52 Week High
$8.24
$4.42

Technical Indicators

Market Signals
Indicator
RNW
EVO
Relative Strength Index (RSI) 53.51 23.24
Support Level $5.20 N/A
Resistance Level $6.56 $3.36
Average True Range (ATR) 0.19 0.10
MACD -0.02 -0.07
Stochastic Oscillator 68.14 4.39

Price Performance

Historical Comparison
RNW
EVO

About RNW ReNew Energy Global plc

ReNew Energy Global PLC is a developer and operator of clean energy projects intended to meet India's growing energy needs in an efficient, sustainable and socially responsible manner. The company provides end-to-end solutions in a just and inclusive manner in the areas of clean energy, value-added energy offerings through digitalization, storage, and carbon markets that increasingly are integral to addressing climate change. The company has four reportable segments: wind power and solar power, hydro power and transmission line. It derives maximum revenue from Wind Power segment.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: